Remove what-we-do patient-engagement
article thumbnail

Why Including Patients in FDA Engagement Will Benefit Your Trial

Worldwide Clinical Trials

Patients are the backbone of clinical trials, playing an essential role in the drug development process. However, patients also play a vital role in engaging directly with the FDA. However, patient involvement can provide innumerable benefits to the sponsors, helping them to create well-designed and strongly executed trials.

Trials 242
article thumbnail

What should DTC do?

World of DTC Marketing

Is there a disconnect between what DTC marketers think will happen and what happens with DTC? Ask current patients what drove them to get an Rx for a branded product (MS drug). The results were not what the DTC team expected. Houston, we have a problem. The post What should DTC do?

Branding 243
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Reflection on Shared Moments of Strength and Progress in the Rare Disease Communities

Worldwide Clinical Trials

For others, this rare day is aptly the day we honor rare disease communities. At Worldwide, we are dedicated to amplifying the voices of those directly impacted by rare diseases — patients, caregivers, family members, advocates, and healthcare professionals alike.

article thumbnail

How Kyverna Therapeutics Is Pioneering Cell Therapy for Autoimmune Diseases

XTalks

Affecting millions of people worldwide, autoimmune diseases present a complex and often debilitating set of challenges for patients. To that end, the quest for innovative treatments has led to the convergence of technology, research and patient-centric care.

article thumbnail

We All Have Data. Now What?: Finding Your Edge in the Algorithmic Age

Intouch Solutions

Where, once, we were limited by our data, in an age of AI, where we have more data than we know what to do with, we are only limited by our imaginations. Regarding prompts, what you give AI is what you get. And we don’t stop there. They are rich in potassium and are a popular snack.

Engineer 105
article thumbnail

Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD)

Rethinking Clinical Trials

But there are concerns to developing DCTs including lack of standardization and validation, regulatory and ethical uncertainties, engagement vs. coercion, data security and privacy issues, technological literacy and access, resistance to change and adoption, and lack of “safe” sharing. I think we must.

article thumbnail

Grand Rounds February 9, 2024: Pragmatic Recruitment of Underrepresented Groups – Experience From the Diuretic Comparison Project (Cynthia Hau, MPH)

Rethinking Clinical Trials

It had a pragmatic recruitment model with an embedded design, multicenter study without local study investigators and management teams, and broad recruitment that included patients from all 50 states and Puerto Rico. At the time, more than 95% of VA patients received hydrochlorothiazide for thiazide-type diuretic.